Glenmede Trust Company »

Oruka Therapeutics shares owned by Glenmede Trust Company

Quarter-by-quarter ownership of Oruka Therapeutics (ORKA) shares owned by Glenmede Trust Company from 13F filings

Historical chart of Glenmede Trust Company investment in Oruka Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oruka Therapeutics held by Glenmede Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oruka Therapeutics by Glenmede Trust Company

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.1M 22k 49.05
2025-12-31 $591k 20k 30.31

More positions owned by Glenmede Trust Company

Vanguard Index Fds S&p 500 Etf S&p 500 Etf Shs (VOO)
Apple (AAPL)
Ishares S & P Smallcap 600 Core S&p Scp Etf (IJR)
Microsoft Corporation (MSFT)
Call On Spy 12/18/26 @ 680 Tr Unit Call Option (SPY)
Alphabet Inc Cap Stk Cl A Cap Stk Cl A (GOOGL)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Ishares Russell 2500 Etf Rusel 2500 Etf (SMMD)
Putnam Focused Large Cap Value Etf Focused Lar Cap (PVAL)
Alphabet Inc Cap Stk Cl C Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Vanguard Index Fds Small Cap Etf Small Cp Etf (VB)

View all positions for Glenmede Trust Company

Top funds holding Oruka Therapeutics

FMR
VR Adviser
Fairmount Funds Management
BlackRock
Viking Global Investors
Vanguard Group
Paradigm Biocapital Advisors
Rtw Investments
Deep Track Capital
Vanguard Capital Management
State Street Corporation
Remedium Capital Partners
Perceptive Advisors
Polar Capital Holdings
Citadel Advisors

View all funds holding Oruka Therapeutics